Cas no 109428-30-0 (1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol)

1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol is a specialized carbohydrate derivative with a rigid benzylidene-protected structure, offering unique reactivity in synthetic organic chemistry. Its fused bicyclic framework and anhydride functionality make it a valuable intermediate for stereoselective transformations, particularly in the synthesis of chiral building blocks and modified sugars. The compound’s stability under a range of conditions, combined with its ability to undergo selective ring-opening reactions, enhances its utility in complex molecular design. Researchers favor this derivative for its predictable reactivity and compatibility with diverse protecting group strategies, facilitating applications in medicinal chemistry and glycobiology. Its well-defined stereochemistry further supports precise synthetic modifications.
1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol structure
109428-30-0 structure
Product Name:1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol
CAS No:109428-30-0
MF:C13H14O4
MW:234.247864246368
MDL:MFCD06657645
CID:128424
PubChem ID:58194959
Update Time:2025-05-25

1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol Chemical and Physical Properties

Names and Identifiers

    • (1aS,3aR,7aR,7bS)-6-Phenylhexahydrooxireno[2',3':4,5]pyrano[3,2-d][1,3]dioxine
    • 1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol
    • D-Allitol,1,5:2,3-dianhydro-4,6-O-(phenylmethylene)-
    • 1,5:2,3-anhydro-4,6-O-benzylidene-D-allitol
    • 1,5:2,3-Dianhydro-4,6-O-(phenylmethylene)-D-allitol
    • SCHEMBL200621
    • (1R,2S,4S,7R)-10-phenyl-3,6,9,11-tetraoxatricyclo[5.4.0.0,undecane
    • 109428-30-0
    • N12739
    • W-200797
    • 1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol?
    • (1R,2S,4S,7R)-10-phenyl-3,6,9,11-tetraoxatricyclo[5.4.0.02,4]undecane
    • DS-020973
    • MDL： MFCD06657645
    • Inchi： 1S/C13H14O4/c1-2-4-8(5-3-1)13-15-6-9-11(17-13)12-10(16-12)7-14-9/h1-5,9-13H,6-7H2/t9-,10+,11-,12+,13?/m1/s1
    • InChI Key： BYKNJRIVJRIKQC-UCEQBCCISA-N
    • SMILES： O1[C@H]2CO[C@@H]3COC(C4C=CC=CC=4)O[C@H]3[C@@H]12

Computed Properties

  • Exact Mass: 234.08900
  • Monoisotopic Mass: 234.08920892g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 17
  • Rotatable Bond Count: 1
  • Complexity: 289
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 4
  • Undefined Atom Stereocenter Count : 1
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 0.8
  • Topological Polar Surface Area: 40.2?2

Experimental Properties

  • Refractive Index: 1.552
  • PSA: 40.22000
  • LogP: 1.26680

1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol Customs Data

  • HS CODE：2932999099
  • Customs Data：

    China Customs Code:

    2932999099

    Overview:

    2932999099. Other heterocyclic compounds containing only oxygen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to

    Summary:

    2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
TRC
D416868-10mg
1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol
 109428-30-0
10mg
 $ 75.00 2022-06-05
TRC
D416868-100mg
1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol
 109428-30-0
100mg
 $ 90.00 2022-06-05
TRC
D416868-500mg
1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol
 109428-30-0
500mg
 $1378.00 2023-05-18
TRC
D416868-1g
1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol
 109428-30-0
1g
 $ 485.00 2022-06-05
TRC
D416868-2.5g
1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol
 109428-30-0
2.5g
 $ 4500.00 2023-09-07
Chemenu
CM122115-1g
(1aS,3aR,7aR,7bS)-6-phenylhexahydrooxireno[2',3':4,5]pyrano[3,2-d][1,3]dioxine
 109428-30-0 95%
1g
 $312 2021-08-06
Chemenu
CM122115-1g
(1aS,3aR,7aR,7bS)-6-phenylhexahydrooxireno[2',3'4,5]pyrano[3,2-d][1,3]dioxine
 109428-30-0 95%
1g
 $312 2023-11-25
TRC
D416868-50mg
1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol
 109428-30-0
50mg
 $173.00 2023-05-18
TRC
D416868-250mg
1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol
 109428-30-0
250mg
 $775.00 2023-05-18
eNovation Chemicals LLC
Y1106944-5g
(1aS,3aR,7aR,7bS)-6-phenylhexahydrooxireno[2',3':4,5]pyrano[3,2-d][1,3]dioxine
 109428-30-0 95%
5g
 $1700 2024-07-23

1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol Related Literature

Related Categories

Additional information on 1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol

Comprehensive Overview of 1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol (CAS No. 109428-30-0)

1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol (CAS No. 109428-30-0) is a specialized carbohydrate derivative with significant applications in organic synthesis and pharmaceutical research. This compound, characterized by its unique anhydro and benzylidene functional groups, has garnered attention for its role in the development of novel therapeutic agents and chiral building blocks. Its molecular structure, featuring a D-allitol backbone, makes it a valuable intermediate in asymmetric synthesis and drug discovery.

In recent years, the demand for chiral auxiliaries and sugar-based pharmaceuticals has surged, driven by advancements in green chemistry and sustainable synthesis. Researchers are increasingly exploring compounds like 1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol due to their potential in reducing synthetic steps and minimizing waste. This aligns with the growing focus on environmentally friendly chemical processes, a topic frequently searched in academic and industrial circles.

The compound's benzylidene-protected hydroxyl groups enhance its stability, making it suitable for multi-step reactions. This property is particularly valuable in the synthesis of glycosides and nucleoside analogs, which are pivotal in antiviral and anticancer drug development. As the pharmaceutical industry shifts toward personalized medicine, the need for high-purity intermediates like CAS No. 109428-30-0 has become a hot topic in drug formulation discussions.

Another area of interest is the compound's utility in catalysis and enzymatic studies. Its rigid structure serves as a scaffold for designing enzyme inhibitors, a subject widely explored in biochemical research. With the rise of AI-driven drug discovery, databases frequently query the structural features of such compounds to predict biological activity, further highlighting its relevance.

From a commercial perspective, 1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol is often sourced for custom synthesis projects. Suppliers emphasize its high purity and batch consistency, addressing the stringent requirements of GMP-compliant production. This aligns with the increasing consumer searches for reliable chemical suppliers and quality control standards in fine chemicals.

In summary, CAS No. 109428-30-0 represents a versatile tool in modern chemistry, bridging gaps between academic research and industrial applications. Its multifaceted roles—from chiral synthesis to drug development—underscore its importance in addressing contemporary challenges in science and technology.

109428-30-0 (1,5:2,3-Dianhydro-4,6-O-benzylidene-D-allitol) Related Products

Recommended suppliers
煙臺朗裕新材料科技有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Jiangsu Kolod Food Ingredients Co.,ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jiangsu Kolod Food Ingredients Co.,ltd
Hunan Well Medicine Synthesis Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hunan Well Medicine Synthesis Technology Co., Ltd.
Zhangzhou Sinobioway Peptide Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zhangzhou Sinobioway Peptide Co.,Ltd.
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.